Relationship between aperiodic dynamics and transcriptomic alterations and a neural signature of glioma-induced excitation-inhibition dysregulation. Phase II propensity-matched controlled trial ...
Phase II study of nivolumab and ipilimumab in children and young adults with INI1-negative cancers. Background: The mitogen-activated protein kinase (MAPK) signaling pathway is an essential pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results